[{"Assets_0_Q3_USD":"62557000000.0","CIK":"882095","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.73","CommonStockDividendsPerShareDeclared_3_Q3_USD":"2.19","CommonStockSharesIssued_0_Q3_shares":"1254000000.0","CommonStockSharesOutstanding_0_Q3_shares":"1254000000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"1.43","EarningsPerShareBasic_3_Q3_USD":"2.35","EarningsPerShareDiluted_1_Q3_USD":"1.42","EarningsPerShareDiluted_3_Q3_USD":"2.34","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"78838305412.0","MinorityInterest_0_Q3_USD":"-24000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"6505000000.0","NetIncomeLoss_1_Q3_USD":"1789000000.0","NetIncomeLoss_3_Q3_USD":"2952000000.0","OfficialName":"Gilead Sciences Inc. Common Stock","PaymentsOfDividends_3_Q3_USD":"2794000000.0","ProfitLoss_1_Q3_USD":"1786000000.0","ProfitLoss_3_Q3_USD":"2933000000.0","RevenuesConverted_1_Q3_USD":"7042000000.0","RevenuesConverted_3_Q3_USD":"19892000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"21057000000.0","StockholdersEquity_0_Q3_USD":"21081000000.0","Ticker":"GILD","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"1261000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"1261000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"1255000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"1255000000.0","filed":"20221102","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"GILEAD SCIENCES, INC.","period":"20220930","qtrs":"0","uom":"USD"}]